CareDx Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.21 |
Market Cap |
$1.49 B |
Shares Outstanding |
42.12 M |
Public Float |
35.72 M |
Address |
3260 Bayshore Boulevard Brisbane California 94005 United States |
Employees | - |
Website | http://www.caredxinc.com |
Updated | 07/08/2019 |
CareDx, Inc. operates as a transplant diagnostics company, which offers pre- and post-transplant continuum. It focuses on discovery, development, and commercialization of diagnostic surveillance solutions. Its product includes AlloMap, which aids clinicians in identifying heart transplant recipients with stable allograft function and AlloSure, which is a donor-derived cell free DNA test. |